Browse All
Displaying 1 - 5 of 6
Author:Bigaud, Marc Anthony, Daniel Zipfel, Geraldine Uffelmann, Tatjana Vostiarova, Helena Engelhardt, Volker Nuesslein-Hildesheim, Barbara Kieseier, Bernd
Session Name:S9: MS Biomarkers, Immunology, and Basic Science
Topic:MS and Inflammatory Disease
Program Number:S9.007
Author Institution:Novartis Pharma AG, Basel, Switzerland University of Oxford, Oxford, United Kingdom
Author:Freimer, Miriam Leite, M. Isabel Genge, Angela Hussain, Yessar Kaminski, Henry J. Mantegazza, Renato Utsugisawa, Kimiaki Vu, Tuan Duda, Petra W. Boroojerdi, Babak Vanderkelen, Mark Lowcock, Romana Howard Jr., James F.
Session Name:P1: Autoimmune Neurology: Myasthenia Gravis
Topic:Autoimmune Neurology
Program Number:P1.007
Author Institution:The Ohio State University Wexner Medical Center, Columbus, OH University of Oxford, Oxford, United Kingdom The Montreal Neurological Institute, Montreal, QC, Canada The University of Texas at Austin, Austin, TX George Washington University, Washington, DC Fondazione Istituto Neurologico, Milan, Italy Hanamaki General Hospital, Hanamaki, Japan University of South Florida Morsani College of Medicine, Tampa, FL UCB Pharma, Cambridge, MA, USA, Cambridge, MA UCB Pharma, Monheim, Germany, Monheim, Germany UCB Pharma, Braine L'Alleud, Belgium, Braine L'Alleud, Belgium UCB Pharma, Slough, UK, Slough, United Kingdom The University of North Carolina at Chapel Hill, Chapel Hill, NC
Author:Pansieri, Jonathan Pisa, Marco Yates, Richard Yee, Sydney Esiri, Margaret De Luca, Gabriele
Session Name:P2: MS Immunology and Basic Science
Program Number:P2.003
Author Institution:University of Oxford, Oxford, United Kingdom Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom Green-Templeton College, Oxford, United Kingdom Nuffield Department of Clinical Neurosciences, Oxford, United Kingdom
Author:Finkel, Richard Benguerba, Kamal Gehani, Manish Raju, Dheeraj Faulkner, Eric LaMarca, Nicole Servais, Laurent
Session Name:P7: Child Neurology and Developmental Neurology: Spinomuscular Atrophy/Muscular Dystrophies
Topic:Child Neurology and Developmental Neurology
Program Number:P7.007
Author Institution:St. Jude Children's Research Hospital, Memphis, TN Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland CONEXTS-Real World Evidence, Novartis Healthcare Pvt. Ltd., Hyderabad, India Novartis Gene Therapies, Inc., Bannockburn, IL University of Oxford, Oxford, United Kingdom
Author:Servais, Laurent Benguerba, Kamal De Vivo, Darryl C. Kirschner, Jan Muntoni, Francesco Proud, Crystal Tizzano, Eduardo Quijano-Roy, Susana Desguerre, Isabelle Saito, Kyoko Raju, Dheeraj LaMarca, Nicole Sun, Rui Anderson, Fred Faulkner, Eric Finkel, Richard
Program Number:P7.010
Author Institution:University of Oxford, Oxford, United Kingdom Novartis Gene Therapies Switzerland GmbH, Rotkreuz, Switzerland Columbia University Irving Medical Center, New York, NY Clinic for Neuropediatrics and Muscle Disease, University Medical Center Freiburg, Freiburg, Germany The Dubowitz Neuromuscular Centre, University College London, Great Ormond Street Institute of Child Health & Great Ormond Street Hospital and National Institute of Health Research, Great Ormond Street Hospital Biomedical Research Centre, London, United Kingdom Children’s Hospital of the King’s Daughters, Norfolk, VA Hospital Valle Hebron, Barcelona, Spain Garches Neuromuscular Reference Center (GNMH), APHP Raymond Poincare University Hospital (UVSQ Paris Saclay), Garches, France Hôpital Necker Enfants Malades, APHP, Paris, France Institute of Medical Genetics, Tokyo Women’s Medical University, Tokyo, Japan Novartis Gene Therapies, Inc., Bannockburn, IL Center for Outcomes Research, University of Massachusetts Medical School, Worcester, MA St. Jude Children's Research Hospital, Memphis, TN
